maprotiline has been researched along with MS (Multiple Sclerosis) in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, TJ | 1 |
1 other study available for maprotiline and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Beneficial effects of maprotiline on irritative urinary symptoms in multiple sclerosis.
Topics: Adult; Anthracenes; Drug Evaluation; Female; Humans; Male; Maprotiline; Middle Aged; Multiple Sclero | 1988 |